Test will specifically adjust for isatuximab-induced interference in complete response assessment of multiple myeloma patients Paris, France, January 7, 2020 – Sebia (Lisses, France), a world leader ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

Sebia is the world's leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing. Its systems analyze proteins in order to ...

Two questions were asked to the five biologists: Do you consider that the monoclonal abnormality characterized at diagnosis is still present? Does the immunofixation result suggest an oligoclonal ...